These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27924485)

  • 1. Small Molecules Targeting the miRNA-Binding Domain of Argonaute 2: From Computer-Aided Molecular Design to RNA Immunoprecipitation.
    Bellissimo T; Masciarelli S; Poser E; Genovese I; Del Rio A; Colotti G; Fazi F
    Methods Mol Biol; 2017; 1517():211-221. PubMed ID: 27924485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating Mechanisms of Molecular Recognition Between Human Argonaute and miRNA Using Computational Approaches.
    Jiang H; Zhu L; Héliou A; Gao X; Bernauer J; Huang X
    Methods Mol Biol; 2017; 1517():251-275. PubMed ID: 27924488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small-molecule targeting the microRNA binding domain of argonaute 2 improves the retinoic acid differentiation response of the acute promyelocytic leukemia cell line NB4.
    Masciarelli S; Quaranta R; Iosue I; Colotti G; Padula F; Varchi G; Fazi F; Del Rio A
    ACS Chem Biol; 2014 Aug; 9(8):1674-9. PubMed ID: 24914804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided screening strategy combining surface plasmon resonance with nuclear magnetic resonance for identification of small-molecule Argonaute 2 inhibitors.
    Harumoto T; Sato A; Takayama Y; Miyagi H; Saito JI; Shinohara F
    PLoS One; 2020; 15(7):e0236710. PubMed ID: 32735606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of circRNAs for miRNA Targets by Argonaute2 RNA Immunoprecipitation and Luciferase Screening Assays.
    Li Y; Chen B; Huang S
    Methods Mol Biol; 2018; 1724():209-218. PubMed ID: 29322452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive Argonaute-Based RNA Immunoprecipitation for Investigation of Transcriptomic Response to Anti-miR.
    Androsavich JR
    Methods Mol Biol; 2017; 1517():91-102. PubMed ID: 27924476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs.
    Schmidt MF; Korb O; Abell C
    Methods Mol Biol; 2017; 1517():239-249. PubMed ID: 27924487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.
    Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ
    Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ago HITS-CLIP expands microRNA-mRNA interactions in nucleus and cytoplasm of gastric cancer cells.
    Zhang X; Shen B; Cui Y
    BMC Cancer; 2019 Jan; 19(1):29. PubMed ID: 30621629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of AgoshRNA maturation and loading into Ago2.
    Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
    PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying miRNA Targets Using AGO-RIPseq.
    Petri R; Jakobsson J
    Methods Mol Biol; 2018; 1720():131-140. PubMed ID: 29236255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-functional surfaces for the immunocapture of AGO2-bound microRNAs.
    Vaghi V; Potrich C; Lunelli L; Facci P; Pasquardini L; Vanzetti L; Pederzolli C
    Colloids Surf B Biointerfaces; 2016 Oct; 146():746-53. PubMed ID: 27449965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argonaute 2-dependent Regulation of Gene Expression by Single-stranded miRNA Mimics.
    Matsui M; Prakash TP; Corey DR
    Mol Ther; 2016 May; 24(5):946-55. PubMed ID: 26903376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells.
    Noetel A; Elfimova N; Altmüller J; Becker C; Becker D; Lahr W; Nürnberg P; Wasmuth H; Teufel A; Büttner R; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):335-41. PubMed ID: 23041308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for possible miRNA-mRNA associations in a colon cancer cell line.
    Kanematsu S; Tanimoto K; Suzuki Y; Sugano S
    Gene; 2014 Jan; 533(2):520-31. PubMed ID: 23939471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-Based Inhibition of miRNA-Guided Gene Silencing.
    Danner J; Pai B; Wankerl L; Meister G
    Methods Mol Biol; 2017; 1517():199-210. PubMed ID: 27924484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of miRNA-Target RNA Interactions Using CLASH.
    Helwak A; Tollervey D
    Methods Mol Biol; 2016; 1358():229-51. PubMed ID: 26463387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides.
    Geekiyanage H; Rayatpisheh S; Wohlschlegel JA; Brown R; Ambros V
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24213-24223. PubMed ID: 32929008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argonaute binding within human nuclear RNA and its impact on alternative splicing.
    Chu Y; Yokota S; Liu J; Kilikevicius A; Johnson KC; Corey DR
    RNA; 2021 Sep; 27(9):991-1003. PubMed ID: 34108230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.